Poulos Kevin P 4
4 · OPTIMER PHARMACEUTICALS INC · Filed May 17, 2010
Insider Transaction Report
Form 4
Poulos Kevin P
Chief Commerical Officer
Transactions
- Other
Common stock
2010-05-17$9.57/sh+1,068$10,222→ 7,547 total
Footnotes (1)
- [F1]Acquired under the Company's employee stock purchase plan on May 17, 2010.